Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 15, 2015 - Issue 9
Submit an article Journal homepage
1,700
Views
71
CrossRef citations to date
0
Altmetric
Review

BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies

Francesco PivaDepartment of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, ItalyCorrespondence[email protected]
,
Matteo SantoniMedical Oncology, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy,Correspondence[email protected]
,
Marc R MatranaOchsner Cancer Institute, New Orleans, LA, USA,
,
Suma SattiOchsner Cancer Institute, New Orleans, LA, USA,
,
Matteo GiuliettiDepartment of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy
,
Giulia OcchipintiDepartment of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy
,
Francesco MassariMedical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy,
,
Liang ChengDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA,
,
Antonio Lopez-BeltranDepartment of Pathology and Surgery, Faculty of Medicine, Cordoba, Spain,
,
Marina ScarpelliSection of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy
,
Giovanni PrincipatoDepartment of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy
,
Stefano CascinuMedical Oncology, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy,
&
Rodolfo MontironiSection of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, ItalyCorrespondence[email protected]
 show all
Pages 1201-1210 | Published online: 11 Jul 2015

Citations (71)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alessia Cimadamore, Francesco Massari, Matteo Santoni, Veronica Mollica, Vincenzo Di Nunno, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi & Holger Moch. (2020) Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsies. Expert Review of Molecular Diagnostics 20:2, pages 141-150.
Read now
Alessia Cimadamore, Silvia Gasparrini, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Francesco Massari, Francesca Giunchi, Michelangelo Fiorentino, Marina Scarpelli & Rodolfo Montironi. (2018) Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer. Expert Review of Molecular Diagnostics 18:7, pages 645-655.
Read now

Articles from other publishers (69)

Kotaro Takeda, Sheldon Bastacky, Rajiv Dhir, Maedeh Mohebnasab & Gabriela M. Quiroga-Garza. (2024) Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma. Annals of Diagnostic Pathology 68, pages 152223.
Crossref
Grace Lee, Brian M. Shinder, Evita Sadimin, Ryan D. Stephenson & Eric A. Singer. 2024. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology 447 460 .
Serena Astore, Giulia Baciarello, Linda Cerbone & Fabio Calabrò. (2023) Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. Cancer Drug Resistance, pages 517-46.
Crossref
Jiahui He, Tangpeng Xu, Fangrui Zhao, Jin Guo & Qinyong Hu. (2023) SETD2-H3K36ME3: an important bridge between the environment and tumors. Frontiers in Genetics 14.
Crossref
Payal Kapur, Satwik Rajaram & James Brugarolas. (2023) The expanding role of BAP1 in clear cell renal cell carcinoma. Human Pathology 133, pages 22-31.
Crossref
Sarah A. Ackroyd, David Arguello, Pilar Ramos, Haider Mahdi, Adam ElNaggar, Ira Winer, Rob Holloway, Thomas Krivak, Nathaniel Jones, Valerie Galvan Turner, Thomas Herzog, Christina Chu, Jubilee Brown & Gina Mantia-Smaldone. (2023) Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma. Gynecologic Oncology 169, pages 164-171.
Crossref
Derek H Liu, Komal A Dani, Sharath S Reddy, Xiaomeng Lei, Natalie L Demirjian, Darryl H Hwang, Bino A Varghese, Suhn Kyong Rhie, Felix Y. Yap, David I. Quinn, Imran Siddiqi, Manju Aron, Ulka Vaishampayan, Haris Zahoor, Steven Y Cen, Inderbir S Gill & Vinay A Duddalwar. (2023) Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study. Oncology 101:6, pages 375-388.
Crossref
Nóra Ördög, Barbara N Borsos, Hajnalka Majoros, Zsuzsanna Ujfaludi, Gabriella Pankotai-Bodó, Sarolta Bankó, Farkas Sükösd, Levente Kuthi & Tibor Pankotai. (2022) The clinical significance of epigenetic and RNAPII variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker. Translational Oncology 20, pages 101420.
Crossref
ByulA Jee, Eunjeong Seo, Kyunghee Park, Yi Rang Kim, Sun-ju Byeon, Sang Min Lee, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Se Hoon Park, Woong-Yang Park & Minyong Kang. (2022) Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma. Cancers 14:10, pages 2354.
Crossref
Khadijah A. Mitchell & Heinric Williams. (2022) Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes. Urologic Oncology: Seminars and Original Investigations 40:4, pages 126-132.
Crossref
Yonghong Man, Xuejun Shang, Chunyu Liu, Wei Zhang, Qian Huang, Suheng Ma, Rita Shiang, Feng Zhang, Ling Zhang & Zhibing Zhang. (2022) Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma. Current Oncology 29:4, pages 2376-2384.
Crossref
Chunxiu Yang, Jingjing Pang, Jian Xu, He Pan, Yueying Li, Huainian Zhang, Huan Liu & Shu-Yuan Xiao. (2021) LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma. Cancer Cell International 21:1.
Crossref
Jia-xin Chen, Da Xu, Jian-wei Cao, Li Zuo, Zhi-tao Han, Yi-jun Tian, Chuan-min Chu, Wang Zhou, Xiu-wu Pan & Xin-gang Cui. (2021) TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination. Cancer Cell International 21:1.
Crossref
Victor Espinheira Santos, Walter Henriques da Costa, Stephania Martins Bezerra, Isabela Werneck da Cunha, Jayme Quirino Caon Nobre, Eder Silveira BrazãoJrJr, Rafael Ribeiro Meduna, Mauricio Murce Rocha, Lucas Fornazieri & Stenio de Cassio Zequi. (2021) Prognostic Impact of Loss of SETD2 in Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer 19:4, pages 339-345.
Crossref
Kiril Trpkov, Ondrej Hes, Sean R. Williamson, Adebowale J. Adeniran, Abbas Agaimy, Reza Alaghehbandan, Mahul B. Amin, Pedram Argani, Ying-Bei Chen, Liang Cheng, Jonathan I. Epstein, John C. Cheville, Eva Comperat, Isabela Werneck da Cunha, Jennifer B. Gordetsky, Sounak Gupta, Huiying He, Michelle S. Hirsch, Peter A. Humphrey, Payal Kapur, Fumiyoshi Kojima, Jose I. Lopez, Fiona Maclean, Cristina Magi-Galluzzi, Jesse K. McKenney, Rohit Mehra, Santosh Menon, George J. Netto, Christopher G. Przybycin, Priya Rao, Qiu Rao, Victor E. Reuter, Rola M. Saleeb, Rajal B. Shah, Steven C. Smith, Satish Tickoo, Maria S. Tretiakova, Lawrence True, Virginie Verkarre, Sara E. Wobker, Ming Zhou & Anthony J. Gill. (2021) New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Modern Pathology 34:7, pages 1392-1424.
Crossref
Oliver Hommerding, Yves Allory, Pedram Argani, Tarek A. Bismar, Lukas Bubendorf, Sofía Canete-Portillo, Alcides Chaux, Ying-Bei Chen, Liang Cheng, Antonio L. Cubilla, Lars Egevad, Anthony J. Gill, David J. Grignon, Arndt Hartmann, Ondrej Hes, Muhammad T. Idrees, Chia-Sui Kao, Margaret A. Knowles, Leendert H. J. Looijenga, Tamara L. Lotan, Colin C. Pritchard, Mark A. Rubin, Scott A. Tomlins, Theodorus H. Van der Kwast, Elsa F. Velazquez, Joshua I. Warrick, Sean R. Williamson & Glen Kristiansen. (2021) Molekularpathologie bei urologischen TumorenMolecular pathology of urogenital tumors. Der Pathologe 42:3, pages 310-318.
Crossref
Alexander J Gallan, Megan Parilla, Jeremy Segal, Lauren Ritterhouse & Tatjana Antic. (2021) BAP1 -Mutated Clear Cell Renal Cell Carcinoma . American Journal of Clinical Pathology 155:5, pages 718-728.
Crossref
Ninghua Wang, Jing Yuan, Fei Liu, Jun Wei, Yu Liu, Mei Xue & Rui Dong. (2021) NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription. PeerJ 9, pages e10848.
Crossref
Qi Zhang, Yingkun Xu, Zhiyu Zhang, Jianyi Li, Qinghua Xia & Yougen Chen. (2021) Folliculin deficient renal cancer cells exhibit BRCA1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib. Gene 769, pages 145243.
Crossref
Philipp Sievers, Martin Sill, Christina Blume, Arnault Tauziede-Espariat, Daniel Schrimpf, Damian Stichel, David E. Reuss, Helin Dogan, Christian Hartmann, Christian Mawrin, Martin Hasselblatt, Walter Stummer, Uta Schick, Jürgen Hench, Stephan Frank, Ralf Ketter, Leonille Schweizer, Jens Schittenhelm, Stéphanie Puget, Sebastian Brandner, Zane Jaunmuktane, Benno Küsters, Zied Abdullaev, Melike Pekmezci, Matija Snuderl, Miriam Ratliff, Christel Herold-Mende, Andreas Unterberg, Kenneth Aldape, David W. Ellison, Pieter Wesseling, Guido Reifenberger, Wolfgang Wick, Arie Perry, Pascale Varlet, Stefan M. Pfister, David T. W. Jones, Andreas von Deimling & Felix Sahm. (2020) Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1. Acta Neuropathologica 141:2, pages 281-290.
Crossref
Chao Rong, Ran Zhou, Shan Wan, Dan Su, Shou-Li Wang & Jochen Hess. (2021) Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer. Frontiers in Oncology 10.
Crossref
Qian YangJiejie QinGuiying SunCuipeng QiuDi JiangHua YeXiao WangLiping DaiJicun ZhuPeng WangJianying Zhang. (2021) Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays. Clinical and Translational Gastroenterology 12:1, pages e00284.
Crossref
Qiang Wang, Jinding Hu, Weiting Kang, Jin Wang, Yuzhu Xiang, Min Fu, Hui Gao & Zhilong Huang. (2021) Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications. Medicine 100:11, pages e24949.
Crossref
Yi Ding, Khaleel I. Al-Obaidy & Liang Cheng. 2021. Practical Oncologic Molecular Pathology. Practical Oncologic Molecular Pathology 233 244 .
Matteo Santoni, Francesco Piva, Alessia Cimadamore, Matteo Giulietti, Nicola Battelli, Rodolfo Montironi, Laura Cosmai & Camillo Porta. (2020) Exploring the Spectrum of Kidney Ciliopathies. Diagnostics 10:12, pages 1099.
Crossref
Clement Chung. (2020) From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer. American Journal of Health-System Pharmacy 77:24, pages 2064-2073.
Crossref
Subhadra Kumari & Srinivasan Muthusamy. (2020) SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer. European Journal of Cancer Prevention 29:6, pages 556-564.
Crossref
Sean R. Williamson, Anthony J. Gill, Pedram Argani, Ying-Bei Chen, Lars Egevad, Glen Kristiansen, David J. Grignon & Ondrej Hes. (2020) Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. American Journal of Surgical Pathology 44:7, pages e47-e65.
Crossref
Yajuan J. Liu, Jane Houldsworth, Rajyasree Emmadi, Lisa Dyer & Daynna J. Wolff. (2020) Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genetics 244, pages 40-54.
Crossref
Amit Sharma, Hongde Liu, Fabian Tobar‐Tosse, Angela Noll, Tikam Chand Dakal, Huamei Li, Frank G. Holz, Karin U. Loeffler & Martina C. Herwig‐Carl. (2020) Genome organization in proximity to the BAP1 locus appears to play a pivotal role in a variety of cancers . Cancer Science 111:4, pages 1385-1391.
Crossref
Zhan Feng, Lixia Zhang, Zhong Qi, Qijun Shen, Zhengyu Hu & Feng Chen. (2020) Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings. Frontiers in Oncology 10.
Crossref
Wen Cai, Zaoyu Wang, Biao Cai, Yichu Yuan, Wen Kong, Jin Zhang, Yonghui Chen, Qiang Liu, Yiran Huang, Jiwei Huang & Wei Xue. (2019) Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor. International Journal of Clinical Oncology 25:2, pages 338-346.
Crossref
Anna M. Chiarella, Dongbo Lu & Nathaniel A. Hathaway. (2020) Epigenetic Control of a Local Chromatin Landscape. International Journal of Molecular Sciences 21:3, pages 943.
Crossref
Francesco Massari, Vincenzo Di Nunno, Matteo Santoni, Lidia Gatto, Claudia Caserta, Franco Morelli, Elena Zafarana, Francesco Carrozza, Alessandra Mosca, Veronica Mollica, Roberto Iacovelli, Roberto Sabbatini, Camillo Porta & Sergio Bracarda. (2019) Toward a genome-based treatment landscape for renal cell carcinoma. Critical Reviews in Oncology/Hematology 142, pages 141-152.
Crossref
Harika Beste Ökmen, Albert Guvenis & Hadi Uysal. (2019) Predicting the polybromo-1 (PBRM1) mutation of a clear cell renal cell carcinoma using computed tomography images and KNN classification with random subspace. Vibroengineering PROCEDIA 26, pages 30-34.
Crossref
Ankita Bansal, Danielle J. Sanchez, Vivek Nimgaonkar, David Sanchez, Romain Riscal, Nicolas Skuli & M. Celeste Simon. (2019) Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression. Molecular Cancer Research 17:9, pages 1881-1892.
Crossref
Pengsheng Chen, Huan Wang, Wenhao Zhang, Yuling Chen, Yang Lv, Di Wu, Mingzhou Guo & Haiteng Deng. (2019) Loss of BAP1 Results in Growth Inhibition and Enhances Mesenchymal–Epithelial Transition in Kidney Tumor Cells. Molecular & Cellular Proteomics 18:7, pages 1320-1329.
Crossref
Vincenzo Di Nunno, Giorgio Frega, Matteo Santoni, Lidia Gatto, Michelangelo Fiorentino, Rodolfo Montironi, Nicola Battelli, Giovanni Brandi & Francesco Massari. (2019) BAP1 in solid tumors. Future Oncology 15:18, pages 2151-2162.
Crossref
Elizabeth G. Porter, Alisha Dhiman, Basudev Chowdhury, Benjamin C. Carter, Hang Lin, Jane C. Stewart, Majid Kazemian, Michael K. Wendt & Emily C. Dykhuizen. (2019) PBRM1 Regulates Stress Response in Epithelial Cells. iScience 15, pages 196-210.
Crossref
Matteo Santoni, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Francesco Massari, Marina Scarpelli, Andrea Benedetto Galosi, Sergio Bracarda & Rodolfo Montironi. (2019) Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges. Frontiers in Oncology 9.
Crossref
Zhou Jiangqiao, Qiu Tao, Chen Zhongbao, Ma Xiaoxiong, Zhang Long, Zou Jilin & Wang Tianyu. (2019) Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma. Biochemical and Biophysical Research Communications 511:1, pages 165-172.
Crossref
Alessia Cimadamore, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli & Rodolfo Montironi. (2019) Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy. Cancers 11:2, pages 196.
Crossref
Libin Yan, Yangjun Zhang, Beichen Ding, Hui Zhou, Weimin Yao & Hua Xu. (2019) Genetic alteration of histone lysine methyltransferases and their significance in renal cell carcinoma. PeerJ 7, pages e6396.
Crossref
Z. Neviere, P. Berthet, F. Polycarpe, C. Dubos-Arvis, P. Dô & R. Gervais. (2019) Mésothéliomes malins et mutations constitutionnelles du gène BAP1. Revue des Maladies Respiratoires 36:2, pages 241-248.
Crossref
Jingping Liu, Paul D. Hanavan, Katon Kras, Yvette W. Ruiz, Erik P. Castle, Douglas F. Lake, Xianfeng Chen, Daniel O’Brien, Huijun Luo, Keith D. Robertson, Haiwei Gu & Thai H. Ho. (2018) Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation. Journal of Proteome Research.
Crossref
Laetitia Mauge, Arnaud Mejean, Laure Fournier, Helena Pereira, Marie-Christine Etienne-Grimaldi, Emeline Levionnois, Armelle Caty, Sophie Abadie-Lacourtoisie, Stéphane Culine, Sylvestre Le Moulec, Claude Linassier, Christine Théodore, Alain Ravaud, Laurence Albiges, Abel Grine, Eric Tartour, Gérard Milano, Anne-Sophie Gille, Virginie Verkarre, Dominique Helley & Stéphane Oudard. (2018) Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial. Clinical Cancer Research 24:22, pages 5534-5542.
Crossref
Nitya RajRonak ShahZsofia StadlerSemanti MukherjeeJoanne ChouBrian UntchJanet LiVirginia KellyMuyinat OsobaLeonard B. SaltzDiana MandelkerMarc LadanyiMichael F. BergerDavid S. KlimstraDiane Reidy-Lagunes. (2018) Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability. JCO Precision Oncology:2, pages 1-18.
Crossref
Ee Sin Chen. (2018) Targeting epigenetics using synthetic lethality in precision medicine. Cellular and Molecular Life Sciences 75:18, pages 3381-3392.
Crossref
Mohammed Akhtar, Issam A. Al-Bozom & Turki Al Hussain. (2018) Molecular and Metabolic Basis of Clear Cell Carcinoma of the Kidney. Advances in Anatomic Pathology 25:3, pages 189-196.
Crossref
Ying Fang & Xizhong Shen. (2017) Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications. Cancer and Metastasis Reviews 36:4, pages 669-682.
Crossref
Sarah Hopson & Martin J. Thompson. (2017) BAF180: Its Roles in DNA Repair and Consequences in Cancer. ACS Chemical Biology 12:10, pages 2482-2490.
Crossref
Daniel M. Tennenbaum, Brandon J. Manley, Emily Zabor, Maria F. Becerra, Maria I. Carlo, Jozefina Casuscelli, Almedina Redzematovic, Nabeela Khan, Maria E. Arcila, Martin H. Voss, Darren R. Feldman, Robert J. Motzer, Nicole E. Benfante, Jonathan A. Coleman, Paul Russo, James J. Hsieh & Abraham Ari Hakimi. (2017) Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Urologic Oncology: Seminars and Original Investigations 35:8, pages 532.e7-532.e13.
Crossref
Daniele Minardi, Guendalina Lucarini, Giulio Milanese, Rodolfo Montironi & Roberto Di Primio. (2017) Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens. Virchows Archiv 471:1, pages 99-105.
Crossref
Arnault Tauziede-Espariat, Béatrice Parfait, Aurore Besnard, Joëlle Lacombe, Johan Pallud, Sanaa Tazi, Stéphanie Puget, Guillaume Lot, Benoît Terris, Joëlle Cohen, Michel Vidaud, Dominique Figarella-Branger, Franck Monnien, Marc Polivka, Homa Adle-Biassette & Pascale Varlet. (2017) Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis. Brain Pathology.
Crossref
Yang Wang, Wen Gao, Jiali Xu, Yizhi Zhu & Lingxiang Liu. (2017) The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma. Tumor Biology 39:5, pages 101042831769837.
Crossref
Nuri Yigit, Luisa Fernanda Suarez, Lisa Giulino Roth, Attilio Orazi & Wayne Tam. (2017) CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl. American Journal of Clinical Pathology 147:5, pages 453-460.
Crossref
Katarzyna Kluzek, Malgorzata I. Srebniak, Weronika Majer, Agnieszka Ida, Tomasz Milecki, Kinga Huminska, Robert M. van der Helm, Adrian Silesian, Tomasz M. Wrzesinski, Jacek Wojciechowicz, Berna H. Beverloo, Zbigniew Kwias, Hans A.R. Bluyssen & Joanna Wesoly. (2017) Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1 , BAP1 and KDMC5 , genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA . Oncotarget 8:17, pages 28558-28574.
Crossref
D. Morel, G. Almouzni, J.-C. Soria & S. Postel-Vinay. (2017) Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism. Annals of Oncology 28:2, pages 254-269.
Crossref
Lei Liu, Renbo Guo, Xiang Zhang, Yiran Liang, Feng Kong, Jue Wang & Zhonghua Xu. (2017) Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients. BioScience Trends 11:2, pages 214-220.
Crossref
M. Francesca Monn, Liang Cheng, Marina Scarpelli, Antonio Lopez-Beltran & Rodolfo Montironi. (2017) Re: Daniel M. Geynisman. Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features. Eur Urol 2015;68:912–4. European Urology 71:1, pages e27-e28.
Crossref
Klaudia K. Brodaczewska, Cezary Szczylik, Michal Fiedorowicz, Camillo Porta & Anna M. Czarnecka. (2016) Choosing the right cell line for renal cell cancer research. Molecular Cancer 15:1.
Crossref
Caroline Razafinjatovo, Svenja Bihr, Axel Mischo, Ursula Vogl, Manuela Schmidinger, Holger Moch & Peter Schraml. (2016) Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer 16:1.
Crossref
Carlo Messina, Giulia Buzzatti, Chiara Dellepiane, Alessia Cavo, Francesco Tolomeo, Carlo Cattrini & Francesco Boccardo. (2016) Genitourinary tumours in the targeted therapies era. Anti-Cancer Drugs 27:10, pages 917-943.
Crossref
Jiajun Wang, Li Liu, Yang Qu, Wei Xi, Yu Xia, Qi Bai, Ying Xiong, Qilai Long, Jiejie Xu & Jianming Guo. (2016) Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors. The Journal of Urology 196:5, pages 1363-1370.
Crossref
Vassilios Myrianthopoulos, Nicolas Gaboriaud-Kolar, Cynthia TallantMichelle-Lynn Hall, Stylianos Grigoriou, Peter Moore BrownleeOleg FedorovCatherine RogersDavid Heidenreich, Marek Wanior, Nikolaos Drosos, Nikitia Mexia, Pavel SavitskyTina Bagratuni, Efstathios Kastritis, Evangelos Terpos, Panagis FilippakopoulosSusanne Müller, Alexios-Leandros Skaltsounis, Jessica Ann DownsStefan Knapp & Emmanuel Mikros. (2016) Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis. Journal of Medicinal Chemistry 59:19, pages 8787-8803.
Crossref
Ami Wang, Anjali Papneja, Martin Hyrcza, Ayman Al-Habeeb & Danny Ghazarian. (2016) Gene of the month: BAP1 . Journal of Clinical Pathology 69:9, pages 750-753.
Crossref
Francesco Piva, Matteo Santoni, Marina Scarpelli, Alberto Briganti, Antonio Lopez-Beltran, Liang Cheng, Rossana Berardi, Francesco Montorsi & Rodolfo Montironi. (2016) Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912–4. European Urology 70:3, pages e72-e74.
Crossref
David J. Paulucci, John P. Sfakianos, Shalini Singh Yadav & Ketan K. Badani. (2016) BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas. Urologic Oncology: Seminars and Original Investigations 34:6, pages 259.e9-259.e14.
Crossref
Elizabeth G. Porter, Alisha Dhiman, Basudev Chowdhury, Benjamin C. Carter, Hang Lin, Jane C. Stewart, Majid Kazemian, Michael K. Wendt & Emily Dykhuizen. (2018) PBRM1 Regulates the Stress Response in Epithelial Cells. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.